• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类细胞色素c的一种突变增强了内源性凋亡途径,但仅导致血小板减少症。

A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.

作者信息

Morison Ian M, Cramer Bordé Elisabeth M, Cheesman Emma J, Cheong Pak Leng, Holyoake Andrew J, Fichelson Serge, Weeks Robert J, Lo Alexandra, Davies Stefan M K, Wilbanks Sigurd M, Fagerlund Robert D, Ludgate Mathew W, da Silva Tatley Fernanda M, Coker Melanie S A, Bockett Nicholas A, Hughes Gillian, Pippig Diana A, Smith Mark P, Capron Claude, Ledgerwood Elizabeth C

机构信息

Department of Biochemistry, University of Otago, PO Box 56, Dunedin 9054, New Zealand.

出版信息

Nat Genet. 2008 Apr;40(4):387-9. doi: 10.1038/ng.103. Epub 2008 Mar 16.

DOI:10.1038/ng.103
PMID:18345000
Abstract

We report the first identified mutation in the gene encoding human cytochrome c (CYCS). Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation. The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro. Notably, the family has no other phenotypic indication of abnormal apoptosis, implying that cytochrome c activity is not a critical regulator of most physiological apoptosis.

摘要

我们报告了人类细胞色素c(CYCS)编码基因中首次发现的突变。在一个因血小板生成失调导致常染色体显性血小板减少症的家族中,在整个真核生物中都不变的甘氨酸41被丝氨酸取代。该突变产生了一种在体外具有增强凋亡活性的细胞色素c变体。值得注意的是,该家族没有其他异常凋亡的表型迹象,这意味着细胞色素c活性并非大多数生理性凋亡的关键调节因子。

相似文献

1
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.人类细胞色素c的一种突变增强了内源性凋亡途径,但仅导致血小板减少症。
Nat Genet. 2008 Apr;40(4):387-9. doi: 10.1038/ng.103. Epub 2008 Mar 16.
2
Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and death.先天性血小板减少症与细胞色素 C 突变:生死攸关。
Semin Thromb Hemost. 2011 Sep;37(6):664-72. doi: 10.1055/s-0031-1291376. Epub 2011 Nov 18.
3
Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.来自CYCS突变相关血小板减少症的巨核细胞通过前血小板依赖性和非依赖性过程释放血小板。
Br J Haematol. 2017 Jan;176(2):268-279. doi: 10.1111/bjh.14421. Epub 2016 Nov 11.
4
The Y49H cytochrome c variant enhances megakaryocytic maturation of K-562 cells.Y49H 细胞色素 c 变体增强 K-562 细胞的巨核细胞成熟。
Biochim Biophys Acta Mol Basis Dis. 2024 Jun;1870(5):167134. doi: 10.1016/j.bbadis.2024.167134. Epub 2024 Mar 26.
5
Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation.Bax和Bid协同作用,通过释放线粒体细胞色素c及随后的半胱天冬酶激活,引发T11TS介导的胶质瘤细胞凋亡。
Int Immunol. 2008 Dec;20(12):1489-505. doi: 10.1093/intimm/dxn109. Epub 2008 Oct 17.
6
Requirement of cytochrome c for apoptosis in human cells.细胞色素c对人类细胞凋亡的需求。
Cell Death Differ. 2006 Dec;13(12):2062-7. doi: 10.1038/sj.cdd.4401968. Epub 2006 May 26.
7
Re-examining the role of cytochrome c in cell death.重新审视细胞色素c在细胞死亡中的作用。
Nat Genet. 2008 Apr;40(4):379-80. doi: 10.1038/ng0408-379.
8
A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia.一个新的 CYCS 突变位于 CYCS C 末端结构域的α螺旋中,导致非综合征性血小板减少症。
Clin Genet. 2018 Dec;94(6):548-553. doi: 10.1111/cge.13423. Epub 2018 Sep 3.
9
Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance.巨轮不停转动:凋亡小体调控及其在化疗耐药中的作用
Cell Death Differ. 2008 Mar;15(3):443-52. doi: 10.1038/sj.cdd.4402265. Epub 2007 Nov 2.
10
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin.在一大群意大利不明原因遗传性血小板减少症患者中未发现CYCS基因突变。
Platelets. 2009 Feb;20(1):72-3. doi: 10.1080/09537100802485129.

引用本文的文献

1
Cytosolic cytochrome c represses ferroptosis.胞质细胞色素c抑制铁死亡。
Cell Metab. 2025 Jun 3;37(6):1326-1343.e10. doi: 10.1016/j.cmet.2025.03.014. Epub 2025 Apr 14.
2
Mutations of the Electron Transport Chain Affect Lifespan and ROS Levels in .电子传递链的突变影响[具体生物名称未给出]的寿命和活性氧水平。
Antioxidants (Basel). 2025 Jan 10;14(1):76. doi: 10.3390/antiox14010076.
3
Phosphorylation of cytochrome c at tyrosine 48 finely regulates its binding to the histone chaperone SET/TAF-Iβ in the nucleus.细胞色素 c 酪氨酸 48 位的磷酸化精细调节其在核内与组蛋白伴侣 SET/TAF-Iβ 的结合。
Protein Sci. 2024 Dec;33(12):e5213. doi: 10.1002/pro.5213.
4
Compound K Promotes Megakaryocytic Differentiation by NLRP3 Inflammasome Activation.化合物 K 通过 NLRP3 炎症小体激活促进巨核细胞分化。
Biomolecules. 2024 Oct 4;14(10):1257. doi: 10.3390/biom14101257.
5
A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study.一种导致血小板减少症4的新型CYCS基因变异降低半胱天冬酶活性:三代研究
Br J Haematol. 2024 Dec;205(6):2450-2458. doi: 10.1111/bjh.19694. Epub 2024 Aug 27.
6
Diverse functions of cytochrome c in cell death and disease.细胞死亡和疾病中细胞色素 c 的多种功能。
Cell Death Differ. 2024 Apr;31(4):387-404. doi: 10.1038/s41418-024-01284-8. Epub 2024 Mar 23.
7
Altered conformational dynamics contribute to species-specific effects of cytochrome c mutations on caspase activation.构象动力学的改变导致细胞色素 c 突变对半胱天冬酶激活的种属特异性效应。
J Biol Inorg Chem. 2024 Mar;29(2):169-176. doi: 10.1007/s00775-024-02044-2. Epub 2024 Mar 12.
8
Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework.使用临床基因组资源基因注释框架评估与止血和血栓形成相关基因的临床有效性。
J Thromb Haemost. 2024 Mar;22(3):645-665. doi: 10.1016/j.jtha.2023.11.011. Epub 2023 Nov 26.
9
"CHildren with Inherited Platelet disorders Surveillance" (CHIPS) retrospective and prospective observational cohort study by Italian Association of Pediatric Hematology and Oncology (AIEOP).意大利儿科血液学和肿瘤学协会(AIEOP)开展的“遗传性血小板疾病患儿监测”(CHIPS)回顾性和前瞻性观察性队列研究。
Front Pediatr. 2022 Nov 22;10:967417. doi: 10.3389/fped.2022.967417. eCollection 2022.
10
Cytochrome c: Using Biological Insight toward Engineering an Optimized Anticancer Biodrug.细胞色素c:利用生物学见解设计优化的抗癌生物药物。
Inorganics (Basel). 2021 Nov;9(11). doi: 10.3390/inorganics9110083. Epub 2021 Nov 16.